Item 4.02. Non-Reliance on Previously Issued Financial Statements or a Related
Audit Report or Completed Interim Review.
European Biotech Acquisition Corp. (the "Company") previously presented a
portion of its shares of Class A ordinary shares subject to redemption (the
"Class A Shares") as permanent equity because the Company's certificate of
incorporation does not permit redemptions of Class A Shares that would cause the
Company's net tangible assets to be less than $5,000,001. After discussion and
evaluation, including with the Company's independent registered public
accounting firm, Marcum LLP ("Marcum"), the Company has concluded that all Class
A Shares should be classified as temporary equity because such shares can be
redeemed or become redeemable subject to the occurrence of events outside the
Company's sole control.
On November 22, 2021, the Audit Committee of the Board of Directors of the
Company concluded, after discussion with the Company's management, that the
Company's audited balance sheet as of March 18, 2021 filed as Exhibit 99.1 to
the Company's Current Report on Form 8-K filed with the SEC on March 24, 2021
and its balance sheets as of March 31, 2021 and June 30, 2021 included in its
Quarterly Reports on Form 10-Q filed on June 22, 2021 and August 18, 2021,
respectively, should no longer be relied upon due to changes required to
classification of temporary equity and permanent equity described above. The
Company has reflected this reclassification of equity in its upcoming Quarterly
Report on Form 10-Q for the quarterly period ended September 30, 2021 to be
filed with the SEC and plans to amend the Current Report on Form 8-K filed on
March 24, 2021 to file the revised audited balance sheet as of March 18, 2021.
The Company's management has concluded that in light of the classification error
described above, a material weakness exists in the Company's internal control
over financial reporting and that the Company's disclosure controls and
procedures were not effective.
The Company does not expect any of the above changes will have any impact on its
cash position and cash held in the trust account.
In addition, the audit report of Marcum included in Exhibit 99.1 to the
Company's Form 8-K filed on March 24, 2021 should no longer be relied upon.
© Edgar Online, source Glimpses